Erasca Balance Sheet
NASDAQ: ERASHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Erasca financial position
At the end of fiscal 2025, Erasca reported total assets of $396.2 million, down 21.2% from a year earlier against total liabilities of $71.0 million. Shareholders' equity stood at $325.2 million, or 82.1% of assets. The company held $73.8 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 10.04, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Erasca balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 73.81M | 67.74M | 93.08M | 284.22M | 360.49M | 65.38M |
| Short-Term Investments | 202.27M | 230.57M | 219.28M | 151.40M | 53.99M | 53.33M |
| Total Current Assets | 286.24M | 308.79M | 320.68M | 444.50M | 420.02M | 119.99M |
| Property, Plant & Equipment | 13.30M | 16.32M | 22.33M | 24.82M | 15.95M | 1.85M |
| Long-Term Investments | 65.72M | 142.16M | 9.64M | — | 44.77M | — |
| Total Assets | 396.15M | 502.53M | 395.30M | 514.91M | 501.42M | 124.83M |
| Accounts Payable | 981.00K | 468.00K | 2.00M | 23.05M | 4.68M | 878.00K |
| Total Current Liabilities | 28.51M | 31.39M | 26.16M | 48.69M | 26.22M | 13.68M |
| Total Liabilities | 70.98M | 79.03M | 78.61M | 103.06M | 44.89M | 17.40M |
| Shareholders' Equity | 325.17M | 423.50M | 316.69M | 411.85M | 456.53M | -113.98M |
| Retained Earnings | -892.21M | -767.66M | -606.01M | -480.97M | -238.17M | -115.40M |
| Net Cash (Debt) | 276.07M | 298.31M | 312.35M | 435.62M | 414.48M | 118.70M |
| Shares Outstanding | 284.16M | 283.22M | 151.09M | 149.33M | 119.10M | 21.92M |
This table shows 6 annual periods of Erasca's balance sheet, from FY 2025 back to FY 2020, across 13 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow ERAS's reporting calendar. What is a balance sheet?